Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FDQYV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,273
Award facts
- Contract value 100% obligated
- $10,273.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,273.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of September 5, 2025, represents a specific fulfillment under the company's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026. The delivery order carries no set-aside designation, allowing the vendor to compete on an unrestricted basis while leveraging its woman-owned small business status.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's broader contract portfolio with DLA encompasses an extensive range of pharmaceutical products spanning oncology treatments, vaccines, contraceptive devices, and specialty auto-injectors. This particular delivery order for Xolair, a biologic medication used in immunology treatment, exemplifies the company's role in supporting military health system requirements through the DLA's pharmaceutical supply program.
Quick answers
Who was awarded contract SPE2DB25FDQYV?
SPE2DB25FDQYV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FDQYV worth?
The government has obligated $10,273 on SPE2DB25FDQYV.
Is contract SPE2DB25FDQYV an order under another contract?
Yes. SPE2DB25FDQYV is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQYV competed?
The extent of competition for SPE2DB25FDQYV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award